Quantitative SPECT/CT Imaging of 177Lu with In Vivo Validation in Patients Undergoing Peptide Receptor Radionuclide Therapy

被引：0
|
作者：
J. C. Sanders
T. Kuwert
J. Hornegger
P. Ritt
机构：
[1] University of Erlangen-Nuremberg,Pattern Recognition Lab, Department of Computer Science
[2] University of Erlangen-Nuremberg,Clinic of Nuclear Medicine, University Hospital Erlangen
来源：
Molecular Imaging and Biology | 2015年 / 17卷
关键词：
Quantitative SPECT; [; Lu]DOTATATE; Peptide receptor radionuclide therapy; Dosimetry;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：585 / 593
页数：8
相关论文
共 50 条
  • [31] Dual-Isotope Peptide Receptor Radionuclide Therapies with 177Lu and 90Y: Is Quantitative Imaging Possible?
    Miller, C.
    Rahmim, A.
    Celler, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S825 - S825
  • [32] A Proposed Calibration Technique for Quantitative 177Lu Measurements in SPECT/CT
    Fenwick, A. J.
    Merrett, J. L.
    Green, A. J.
    Johansson, L.
    D'Arienzo, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S553 - S553
  • [33] How We Do It: A Multidisciplinary Approach to 177LU DOTATATE Peptide Receptor Radionuclide Therapy
    Burkett, Brian J.
    Dundar, Ayca
    Young, Jason R.
    Packard, Annie T.
    Johnson, Geoffrey B.
    Halfdanarson, Thorvardur R.
    Eiring, Rachel A.
    Gansen, Denise N.
    Patton, Cynthia M.
    Kendi, A. Tuba
    RADIOLOGY, 2021, 298 (02) : 261 - 274
  • [34] A dosimetry procedure for organs-at-risk in 177Lu peptide receptor radionuclide therapy of patients with neuroendocrine tumours
    Marin, Gwennaelle
    Vanderlinden, Bruno
    Karfis, Ioannis
    Guiot, Thomas
    Wimana, Zena
    Reynaert, Nick
    Vandenberghe, Stefaan
    Flamen, Patrick
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2018, 56 : 41 - 49
  • [35] 177Lu Dotatate Peptide Receptor Radionuclide Therapy in Chronic Kidney Disease Patients: A Single Center Experience
    Manohar, Sandhya
    Kompotiatis, Panagiotis
    Halfdanarson, Thorvardur R.
    Hobday, Timothy J.
    Thorpe, Matthew
    Johnson, Geoffrey B.
    Kendi, Ayse T.
    Leung, Nelson
    PANCREAS, 2022, 51 (03) : E45 - E46
  • [36] Dosimetric Evaluation of 177Lu Peptide Receptor Radionuclide Therapy Using GATE and Planet Dose
    Stamouli, Ioanna
    Nanos, Thomas
    Chatzipapas, Konstantinos
    Papadimitroulas, Panagiotis
    Zoglopitou, Lydia-Aggeliki
    Kalathas, Theodoros
    Katsakiori, Paraskevi F.
    Makridou, Anna
    Kagadis, George C.
    APPLIED SCIENCES-BASEL, 2023, 13 (17):
  • [37] Phantom study for activity quantification of 177Lu SPECT/CT imaging
    Ferrando, O.
    Chimenz, A.
    Riondato, M.
    Rambaldi, G.
    Foppiano, F.
    Ciarmiello, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S823 - S823
  • [38] Feasibility of individual dosimetry using RT-PHITS for patients with SPECT/CT imaging after 177Lu-DOTATATE peptide receptor radionuclide therapy
    Miwa, Kenta
    Kakino, Ryo
    Sato, Tatsuhiko
    Furuta, Takuya
    Miyaji, Noriaki
    Yamao, Tensho
    Yamashita, Kosuke
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [39] Quantitative 177Lu-SPECT/CT imaging and validation of a commercial dosimetry software
    D'ambrosio, L.
    Aloj, L.
    Madesani, D.
    Morisco, A.
    Aurilio, M.
    Prisco, A.
    Di Gennaro, F.
    Lastoria, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S263 - S263
  • [40] In Vivo Instability of 177Lu-DOTATATE During Peptide Receptor Radionuclide Therapy
    Lubberink, Mark
    Wilking, Helena
    Ost, Amalia
    Ilan, Ezgi
    Sandstrom, Mattias
    Andersson, Camilla
    Fross-Baron, Katarzyna
    Velikyan, Irina
    Sundin, Anders
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (09) : 1337 - 1340
12345